Is DERM or DMRA more undervalued in 2026?

CirclFi compares Journey Medical Corporation (DERM) and Damora Therapeutics, Inc. (DMRA) using 13 institutional-grade valuation models. DERM has a Quality of Company score of 5.7/10 while DMRA scores 4.8/10.

Which is a better buy — DERM or DMRA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do DERM and DMRA valuations compare?

DERM at $6.31 and DMRA at $24.88 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

DERM vs DMRA Valuation Comparison 2026 — Intrinsic Value Analysis

DERM

Pharmaceutical Preparations

Journey Medical Corporation

Quality

5.7

out of 10

Value Trap

SAFE

Price

$6.31

Last close

Models

11/13

Active

DMRA

Pharmaceutical Preparations

Damora Therapeutics, Inc.

Quality

4.8

out of 10

Value Trap

SAFE

Price

$24.88

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	DERM Fair Value	DERM Upside	DMRA Fair Value	DMRA Upside
Bayesian DCF	Intrinsic	$1.26	-80.1%	$7.39	-70.3%
Earnings Power Value	Intrinsic	$1.89	-63.5%	$6.07	-75.0%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for DERM vs DMRA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

DERM vs DMRA — Which Stock Is More Undervalued?

DERM scores higher with a 5.7/10 quality rating vs DMRA's 4.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Journey Medical Corporation (DERM) and Damora Therapeutics, Inc. (DMRA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

DERM currently trades at $6.31 with a QOC of 5.7/10, while DMRA trades at $24.88 with a QOC of 4.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).